Literature DB >> 30604117

VA Primary Care and Mental Health Providers' Comfort with Genetic Testing: Survey Results from the PRIME Care Study.

Leland E Hull1, Kevin G Lynch2,3, David W Oslin2,3.   

Abstract

Year:  2019        PMID： 30604117      PMCID： PMC6544768          DOI： 10.1007/s11606-018-4776-0

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.

Authors:  E J Stanek; C L Sanders; K A Johansen Taber; M Khalid; A Patel; R R Verbrugge; B C Agatep; R E Aubert; R S Epstein; F W Frueh
Journal:  Clin Pharmacol Ther       Date:  2012-01-25       Impact factor: 6.875

Review 2.  Pharmacogenomics in the clinic.

Authors:  Mary V Relling; William E Evans
Journal:  Nature       Date:  2015-10-15       Impact factor: 49.962

Review 3.  Comparison of delivery strategies for pharmacogenetic testing services.

Authors:  Susanne B Haga; Jivan Moaddeb
Journal:  Pharmacogenet Genomics       Date:  2014-03       Impact factor: 2.089

4.  Primary care physicians' knowledge of and experience with pharmacogenetic testing.

Authors:  S B Haga; W Burke; G S Ginsburg; R Mills; R Agans
Journal:  Clin Genet       Date:  2012-07-03       Impact factor: 4.438
  4 in total
  9 in total

1.  Pharmacogenomics courses in pharmacy school curricula.

Authors:  Susanne B Haga; Jivan Moaddeb
Journal:  Pharmacogenomics       Date:  2019-06       Impact factor: 2.533

2.  Identifying End Users' Preferences about Structuring Pharmacogenetic Test Orders in an Electronic Health Record System.

Authors:  Leland E Hull; Jason L Vassy; Annjanette Stone; Catherine C Chanfreau-Coffinier; Craig W Heise; Victoria M Pratt; Ronald Przygodzki; Corrine I Voils; Deepak Voora; Jessica Wang-Rodriguez; Steven A Schichman; Maren T Scheuner
Journal:  J Mol Diagn       Date:  2020-10       Impact factor: 5.568

3.  Patient characteristics, experiences and perceived value of pharmacogenetic testing from a single testing laboratory.

Authors:  Susanne B Haga; Yiling Liu
Journal:  Pharmacogenomics       Date:  2019-06       Impact factor: 2.533

4.  Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.

Authors:  David W Oslin; Kevin G Lynch; Mei-Chiung Shih; Erin P Ingram; Laura O Wray; Sara R Chapman; Henry R Kranzler; Joel Gelernter; Jeffrey M Pyne; Annjanette Stone; Scott L DuVall; Lisa Soleymani Lehmann; Michael E Thase; Muhammad Aslam; Steven L Batki; James M Bjork; Frederic C Blow; Lisa A Brenner; Peijun Chen; Shivan Desai; Eric W Dieperink; Scott C Fears; Matthew A Fuller; Courtney S Goodman; David P Graham; Gretchen L Haas; Mark B Hamner; Amy W Helstrom; Robin A Hurley; Michael S Icardi; George J Jurjus; Amy M Kilbourne; Julie Kreyenbuhl; Daniel J Lache; Steven P Lieske; Julie A Lynch; Laurence J Meyer; Cristina Montalvo; Sumitra Muralidhar; Michael J Ostacher; Gayla Y Paschall; Paul N Pfeiffer; Susana Prieto; Ronald M Przygodzki; Mohini Ranganathan; Mercedes M Rodriguez-Suarez; Hannah Roggenkamp; Steven A Schichman; John S Schneeweis; Joseph A Simonetti; Stuart R Steinhauer; Trisha Suppes; Maria A Umbert; Jason L Vassy; Deepak Voora; Ilse R Wiechers; Amanda E Wood
Journal:  JAMA       Date:  2022-07-12       Impact factor: 157.335

5.  Analysis of genetic and clinical factors associated with buprenorphine response.

Authors:  Richard C Crist; Rachel Vickers-Smith; Rachel L Kember; Christopher T Rentsch; Heng Xu; E Jennifer Edelman; Emily E Hartwell; Kyle M Kampman; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2021-08-28       Impact factor: 4.852

6.  Best-worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy.

Authors:  Ramzi G Salloum; Jeffrey R Bishop; Amanda L Elchynski; D Max Smith; Elizabeth Rowe; Kathryn V Blake; Nita A Limdi; Christina L Aquilante; Jill Bates; Amber L Beitelshees; Amber Cipriani; Benjamin Q Duong; Philip E Empey; Christine M Formea; J Kevin Hicks; Pawel Mroz; David Oslin; Amy L Pasternak; Natasha Petry; Laura B Ramsey; Allyson Schlichte; Sandra M Swain; Kristen M Ward; Kristin Wiisanen; Todd C Skaar; Sara L Van Driest; Larisa H Cavallari; Sony Tuteja
Journal:  Implement Sci Commun       Date:  2022-05-14

7.  Research Lifecycle to Increase the Substantial Real-world Impact of Research: Accelerating Innovations to Application.

Authors:  Amy M Kilbourne; Melissa Z Braganza; Nicholas W Bowersox; David E Goodrich; Isomi Miake-Lye; Nicole Floyd; Melissa M Garrido; Austin B Frakt; Christopher T Bever; Ryan Vega; Rachel Ramoni
Journal:  Med Care       Date:  2019-10       Impact factor: 2.983

8.  Primary care and mental health providers' perceptions of implementation of pharmacogenetics testing for depression prescribing.

Authors:  Bonnie M Vest; Laura O Wray; Laura A Brady; Michael E Thase; Gregory P Beehler; Sara R Chapman; Leland E Hull; David W Oslin
Journal:  BMC Psychiatry       Date:  2020-10-28       Impact factor: 3.630

9.  Pharmacogenetics in Psychiatry: Perceived Value and Opinions in a Chilean Sample of Practitioners.

Authors:  Juan Undurraga; Ignacio Bórquez-Infante; Nicolás A Crossley; Miguel L Prieto; Gabriela M Repetto
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.